Guideline for PET/CT imaging of neuroendocrine neoplasms with Ga-DOTA-conjugated somatostatin receptor targeting peptides and F-DOPA.

Purpose & Methods: Neuroendocrine neoplasms are a heterogenous group of tumours, for which nuclear medicine plays an important role in the diagnostic work-up as well as in the targeted therapeutic options. This guideline is aimed to assist nuclear medicine physicians in recommending, performing, reporting and interpreting the results of somatostatin receptor (SSTR) PET/CT imaging using Ga-DOTA-conjugated peptides, as well as F-DOPA imaging for various neuroendocrine neoplasms.

Results & Conclusion: The previous procedural guideline by EANM regarding the use PET/CT tumour imaging with Ga-conjugated peptides has been revised and updated with the relevant and recent literature in the field with contribution of distinguished experts.